Cyclerion Therapeutics | 3:首次持股声明-高管 CHICKO RHONDA M.
Cyclerion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Tyndall Capital Partners, L.P.(6.7%)
Cyclerion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Invus Public Equities, L.P.(5.7%),Invus Public Equities Advisors, LLC(5.7%)等
Cyclerion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(6.660%),Abigail P. Johnson(6.660%)
Cyclerion Therapeutics | 4:持股变动声明-董事 Hecht Peter M
Cyclerion Therapeutics | 4:持股变动声明-高管 Graul Regina Margaret
Cyclerion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Slate Path Capital LP(14.6%),David Greenspan(14.6%)
Cyclerion Therapeutics | 3:首次持股声明-董事 Katabi Dina
Cyclerion Therapeutics | 3:首次持股声明-董事 Higgins Michael J
Cyclerion Therapeutics | 3/A:首次持股声明(修正)-总裁 Graul Regina Margaret
Cyclerion Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)
Cyclerion Therapeutics | 3:首次持股声明-总裁 Graul Regina Margaret
Cyclerion Therapeutics | 4:持股变动声明-董事 MCGUIRE TERRANCE
Cyclerion Therapeutics | 4:持股变动声明-董事 Hecht Peter M
Cyclerion Therapeutics | 4:持股变动声明-董事 DESOUZA ERROL B
Cyclerion Therapeutics | 4:持股变动声明-董事 Hyman Steven
Cyclerion Therapeutics | SC 13G:超过5%持股股东披露文件-Tyndall Capital Partners, LP(5.05%)
Cyclerion Therapeutics | 4:持股变动声明-董事 MCGUIRE TERRANCE
Cyclerion Therapeutics | D:发行公告
Cyclerion Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)
暂无数据